Today: 30 April 2026
Rocket Lab stock slips after CFO’s $103 million share sale filing; what investors watch next
9 January 2026
1 min read

Rocket Lab stock slips after CFO’s $103 million share sale filing; what investors watch next

New York, January 8, 2026, 18:29 EST — After-hours

  • Shares closed down 1.2% and edged lower in after-hours trading
  • SEC filing showed CFO Adam Spice sold about 1.37 million shares under a 10b5-1 plan
  • Next catalysts include Friday’s U.S. jobs report and Rocket Lab’s expected Feb. 26 earnings

Rocket Lab Corp (RKLB) shares dipped in after-hours trading on Thursday after a regulatory filing showed Chief Financial Officer Adam C. Spice sold about $103 million of stock under a Rule 10b5-1 plan, which sets trades in advance. The stock closed down 1.2% at $83.08 and slipped to $82.98 after the bell, leaving the space company valued at about $44.4 billion. Spice sold 1,365,665 shares at weighted-average prices ranging from $71.49 to $78.24 and exercised options to buy 731,330 shares, the filing showed.

The timing matters because Rocket Lab has been moving fast since the calendar flipped. Shares jumped 10.1% on Tuesday to a record close of $86.03, then fell 2.3% on Wednesday before Thursday’s slide, according to price data.

Rocket Lab has also been trading in the slipstream of a broader defense bid. Lockheed Martin and Northrop Grumman rose on Thursday after President Donald Trump proposed a 50% increase in military spending, while the Nasdaq ended lower, Investors.com reported.

Rule 10b5-1 plans are meant to reduce the risk of insiders being accused of trading on nonpublic information by setting sale instructions ahead of time. They can still hit sentiment when a stock is stretched and liquidity is thin after the close.

The next hard checkpoint is earnings. Rocket Lab is expected to report results on Feb. 26, and investors will look for updates on conversion of contract awards into revenue, margins and program timelines tied to its space-systems and launch businesses.

Before that, traders face Friday’s U.S. employment report for December, due at 8:30 a.m. ET. A surprise either way could swing rate expectations and risk appetite, which tends to show up quickly in high-volatility growth stocks.

The space trade has been choppy elsewhere, too. AST SpaceMobile fell 12% on Wednesday after Scotiabank analyst Andres Coello downgraded the stock to “sell” and flagged valuation risk, Barron’s reported. Barron’s

Rocket Lab’s run leaves little room for operational misses. A launch failure, delays on new vehicle development or slower execution on government satellite work could bring the focus back to spending levels and the path to consistent cash generation.

Shares reopen on Friday with the jobs report in the background and the insider sale still fresh. The next company-specific catalyst is the expected Feb. 26 earnings update.

Stock Market Today

  • SoftBank Targets $100 Billion U.S. IPO for AI Robotics Spinout Roze
    April 30, 2026, 8:37 AM EDT. SoftBank Group plans to spin off Roze, an AI and robotics unit focused on automating server farm construction, aiming for a U.S. IPO valued at about $100 billion. The listing could occur in the second half of 2026, driven by CEO Masayoshi Son. However, internal resistance exists over the valuation and timeline, partly due to geopolitical tensions in the Middle East. Roze's assets might include SoftBank's energy, land, and infrastructure holdings, plus ABB Robotics acquired last year. The IPO proceeds would support Son's large financial commitments, including $30 billion invested in OpenAI. This move ties into the $500 billion Stargate project, a national AI infrastructure initiative. SoftBank's stock has risen over 18% year-to-date.

Latest article

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Gas Prices Hit $4.30: Why America’s Oil Boom Isn’t Saving Drivers

Gas Prices Hit $4.30: Why America’s Oil Boom Isn’t Saving Drivers

30 April 2026
U.S. gasoline prices hit $4.30 a gallon Thursday, the highest since 2022, as the Iran war and refinery issues drove up crude costs. Brent crude briefly topped $126 a barrel before settling at $121.90. U.S. crude output reached a record 13.6 million barrels per day last year, but high exports and falling inventories tightened supplies. Michigan saw prices jump to $4.58 amid regional refinery problems.
Oracle stock slips as tech cools on AI spending doubts; payrolls next test
Previous Story

Oracle stock slips as tech cools on AI spending doubts; payrolls next test

AppLovin stock slips as Wells Fargo lifts target and traders turn to jobs data, earnings next
Next Story

AppLovin stock slips as Wells Fargo lifts target and traders turn to jobs data, earnings next

Go toTop